New research gives hope for sight recovery in stroke survivors
Researchers have used MRI imaging to map visual brain activity in stroke survivors with sight loss that gives new hope for rehabilitation and recovery.
Jan 6, 2022
0
151
Researchers have used MRI imaging to map visual brain activity in stroke survivors with sight loss that gives new hope for rehabilitation and recovery.
Jan 6, 2022
0
151
The use of anti-depressant drugs in England has soared by 28 percent in the past three years, coinciding with the country's fall into recession and the global economic crisis, new figures showed Friday.
Dec 30, 2011
3
0
Technology capable of diagnosing Alzheimer's disease long before its symptoms appear won a coveted honor for innovation at the South by Southwest (SXSW) festival.
Mar 13, 2013
0
0
(Medical Xpress)—Cardiac deaths during this week's storm have occurred not just while people are shoveling but while they have been using snowblowers as well.
Nov 21, 2014
0
2
Pfizer and BioNTech on Monday submitted preliminary clinical data to US health authorities as part of their effort to seek authorization for a third dose of their COVID-19 vaccine for all Americans.
Aug 16, 2021
1
843
The Accreditation Council for Graduate Medical Education (ACGME) today announced major changes in how the nation's medical residency programs will be accredited in the years ahead, putting in place an outcomes-based evaluation ...
Feb 22, 2012
0
0
Scientists are getting their first peek at the genes of nearly 100,000 Americans in what's considered a uniquely diverse genomic database—part of a quest to reduce health disparities and end cookie-cutter care.
Mar 17, 2022
0
3
How can health care systems increase diversity and inclusion in their workforce?
Jan 7, 2024
0
0
San Diego startup AltheaDx, which developed a molecular test designed to guide therapy for depression and anxiety based on a patient's genetics, is being acquired for $65 million in stock and cash.
Apr 7, 2022
0
3
Pharmaceutical giant Bristol-Myers Squibb Company announced it was acquiring Inhibitex, Inc., a company specializing in treatment of hepatitis C, for $2.5 billion (1.9 billion euros).
Jan 8, 2012
0
0